
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Bacillus Subtilis
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Middle East Cell and Gene Therapy | National Institute of Genetic Engineering and Biotechnology
Deal Size : Inapplicable
Deal Type : Inapplicable
COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores
Details : Bacillus Subtilis is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
February 15, 2022
Lead Product(s) : Bacillus Subtilis
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Middle East Cell and Gene Therapy | National Institute of Genetic Engineering and Biotechnology
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Bacillus Subtilis Spore Extract
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : DreamTec Cytokine Limited
Deal Size : Inapplicable
Deal Type : Inapplicable
Oral Neutralizing Antibody Booster for Post-vaccinated People With COVID19 Vaccine
Details : Bacillus Subtilis Spore Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
December 15, 2021
Lead Product(s) : Bacillus Subtilis Spore Extract
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : DreamTec Cytokine Limited
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Bacillus Subtilis
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
The Development of a COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores
Details : Bacillus Subtilis is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
September 27, 2021
Lead Product(s) : Bacillus Subtilis
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
